Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection

INTRODUCTION: Patients with end-stage kidney disease (ESKD) represent a vulnerable group with multiple risk factors that are associated with poor outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Despite established susceptibility to infectious complications and...

Descripción completa

Detalles Bibliográficos
Autores principales: Muir, Luke, Jaffer, Aneesa, Rees-Spear, Chloe, Gopalan, Vignesh, Chang, Fernando Y., Fernando, Raymond, Vaitkute, Gintare, Roustan, Chloe, Rosa, Annachiara, Earl, Christopher, Rajakaruna, Gayathri K., Cherepanov, Peter, Salama, Alan, McCoy, Laura E., Motallebzadeh, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081267/
https://www.ncbi.nlm.nih.gov/pubmed/33942026
http://dx.doi.org/10.1016/j.ekir.2021.03.902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081267/
https://www.ncbi.nlm.nih.gov/pubmed/33942026
http://dx.doi.org/10.1016/j.ekir.2021.03.902

Ejemplares similares